News

• 2026.08.06
  Financial Results(決算資料)
  Supplemental Materials of FY9/26 3Q Consolidated Financial Results
• 2026.08.06
  Financial Results(決算資料)
  Financial Results of 3Q/FY2026
• 2026.07.17
  Other(その他)
  First Half of FY2026 Company Research and Analysis Report (Published by FISCO Ltd.)

• 2026.08.06
  Financial Results
  Supplemental Materials of FY9/26 3Q Consolidated Financial Results
• 2026.08.06
  Financial Results
  Financial Results of 3Q/FY2026
• 2026.05.19
  Financial Results
  Script for 2Q Financial Results Briefing for the Fiscal Year Ending September 2026

• 2026.05.11
  Release
  OLIC Thailand Commences Promotional Activities for "Papilocare® Vaginal Gel"
• 2026.03.24
  Release
  Fuji Pharma and Gedeon Richter Conclude Agreement for Joint Development Projects in Women's Health
• 2026.03.19
  Release
  Notice Regarding Revision of Interim Dividend Forecasts for the Fiscal Year Ending September2026 (62ndFiscal Year)

• 2025.07.25
  Product
  Initiation of Phase Ⅲ clinical trial for the Alyssa® combination tablets
• 2025.06.25
  Product
  Emergency contraceptive pill : LEVONORGESTREL tablet 1.5 mg "F" Notice of Application for Marketing Approval as Switch OTC Drug
• 2019.10.23
  Product
  Manufacturing and marketing approval succession for l'estrogel 0.06% treatment for menopausal disorders

• 2026.07.17
  Other
  First Half of FY2026 Company Research and Analysis Report (Published by FISCO Ltd.)
• 2026.06.01
  Other
  Corporate Report 2026 (English version) has been published
• 2026.01.27
  Other
  FY2025 Company Research and Analysis Report (Published by FISCO Ltd.)